Frazier Financial Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4
Closed -$60 623
2025
Q1
$60 Hold
4
﹤0.01% 583
2024
Q4
$69 Buy
+4
New +$77 ﹤0.01% 623

Other funds holding CLB

Frazier Financial Advisors's CLB Position: Q2 2025 in Review

Frazier Financial Advisors sold out of Core Laboratories (CLB) in Q2 2025, closing a stake of 4 shares — an estimated $60 sold.

Frazier Financial Advisors first reported a position in CLB in Q4 2024 and held it in 2 quarters. The position peaked at $69 in Q4 2024. 191 funds tracked by Wall St. Rank hold CLB as of Q2 2025.

  • Frazier Financial Advisors reported no remaining Core Laboratories position as of Q2 2025 after selling out during the quarter.
  • Frazier Financial Advisors sold 4 Core Laboratories shares in Q2 2025, an estimated $60.
  • Frazier Financial Advisors first reported a position in Core Laboratories in Q4 2024 and held it in 2 quarters.
  • Frazier Financial Advisors's Core Laboratories position peaked at $69 in Q4 2024.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2025.

Based on Frazier Financial Advisors's 13F filing for Q2 2025, filed 28 Jul 2025.